Bausch Health Companies (BHC) Net Income towards Common Stockholders (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Net Income towards Common Stockholders data on file, last reported at -$1.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 1563.95% year-over-year to -$1.4 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.2 billion (down 1412.35% YoY), and the FY2025 full-year result was $120.0 million, up 266.67% from the prior year.
• Net Income towards Common Stockholders slipped to -$1.4 billion in Q1 2026, from -$103.0 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $403.0 million in Q3 2022 to a low of -$1.4 billion in Q1 2026.
• A 5-year average of -$129.8 million and a median of -$77.0 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders soared 12900.0% in 2025 and plunged 1563.95% in 2026, its largest moves.
• Tracing BHC's Net Income towards Common Stockholders over 5 years: stood at -$410.0 million in 2022, then surged by 88.54% to -$47.0 million in 2023, then soared by 308.51% to $98.0 million in 2024, then slumped by 205.1% to -$103.0 million in 2025, then plunged by 1289.32% to -$1.4 billion in 2026.
• Business Quant data shows BHC's Net Income towards Common Stockholders at -$1.4 billion in Q1 2026, -$103.0 million in Q4 2025, and $181.0 million in Q3 2025.